U.S. Markets open in 8 hrs 24 mins
  • S&P Futures

    3,673.75
    +9.25 (+0.25%)
     
  • Dow Futures

    30,009.00
    +77.00 (+0.26%)
     
  • Nasdaq Futures

    12,509.25
    +47.00 (+0.38%)
     
  • Russell 2000 Futures

    1,852.00
    +4.80 (+0.26%)
     
  • Crude Oil

    46.49
    +0.85 (+1.86%)
     
  • Gold

    1,842.60
    +1.50 (+0.08%)
     
  • Silver

    24.18
    +0.04 (+0.18%)
     
  • EUR/USD

    1.2157
    +0.0007 (+0.0608%)
     
  • 10-Yr Bond

    0.9200
    0.0000 (0.00%)
     
  • Vix

    21.28
    +0.11 (+0.52%)
     
  • GBP/USD

    1.3455
    +0.0002 (+0.0148%)
     
  • USD/JPY

    103.9360
    +0.0760 (+0.0732%)
     
  • BTC-USD

    19,243.20
    -14.39 (-0.07%)
     
  • CMC Crypto 200

    377.90
    +3.49 (+0.93%)
     
  • FTSE 100

    6,490.27
    +26.88 (+0.42%)
     
  • Nikkei 225

    26,754.60
    -54.77 (-0.20%)
     

NNOX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Nano-X Imaging Ltd. Shareholders of Class Action and Lead Plaintiff Deadline: November 16, 2020

·2 min read

NEW YORK, NY / ACCESSWIRE / November 16, 2020 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Nano-X Imaging Ltd. ("Nano-X" or "the Company") (NASDAQ:NNOX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Nano-X securities between August 21, 2020, and September 15, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/nnox.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Nano-X's commercial agreements and its customers were fabricated; (2) Nano-X's statements regarding its "novel" Nanox System were misleading as the Company never provided data comparing its images with images from competitors' machines; (3) Nano-X's submission to the U.S. Food and Drug Administration ("FDA") admitted the Nanox System was not original; and (4) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

A class-action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: www.bgandg.com/nnox, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Nano-X, you have until November 16, 2020, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/616930/NNOX-Final-Deadline-Bronstein-Gewirtz-Grossman-LLC-Reminds-Nano-X-Imaging-Ltd-Shareholders-of-Class-Action-and-Lead-Plaintiff-Deadline-November-16-2020